Intelligent Bio Solutions Inc. (Nasdaq: INBS), a leading medical diagnostic company known for its fast, innovative, and non-invasive testing solutions, announced the addition of several key client accounts in the United Kingdom manufacturing sector in the second week of July 2024.
Intelligent Bio Solutions Inc. (Nasdaq: INBS) stock is currently trading above its 10- and 20-day moving averages, indicating a reversal in a slight uptrend. It closed up 3.21% on Monday, July 15, 2024, on lower-than-average volume, making this stock worth monitoring.
These Prominent manufacturer(s), have transitioned from third-party urine testing to the Intelligent Bio Solutions’ “Fingerprinting Drug Screening System”:
- An automotive components manufacturer, operating five (5) sites with 1,200 employees
- A major packaging manufacturer with four (4) sites and approximately 900 employees.
- A renowned beverage manufacturer with two (2) sites and 350 employees.
Intelligent Bio Solutions' "Fingerprint Drug Screening System" is an optimal solution for fast and dependable testing. The quick, non-invasive method allows companies to efficiently test their staff. INBS's cutting-edge Drug Screening System delivers a value-added advantage, tackling safety concerns with precise, on-the-spot testing.
The Intelligent Fingerprinting Drug Screening System detects prevalent drugs of abuse, such as opiates, cocaine, and methamphetamine, using sweat from the fingertips. This approach offers a swift, non-invasive alternative to traditional methods, ensuring employees are "Fit to Work."
Intelligent Bio Solutions Inc. (Nasdaq: INBS) was recently highlighted alongside Trump Media (NASDAQ: DJT), Peraso Inc. (NASDAQ: PRSO), Dyadic International, Inc. (NASDAQ: DYAI), and Catheter Precision, Inc. (NYSE American: VTAK). These stocks have demonstrated recent growth and exhibit promising developments in their respective fields. Read entire news article now.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com
